UCSF banner
Curry International Tuberculosis Center
UCSF home page UCSF Home Page About UCSF UCSF Medical Center





 


Tuberculosis Contact Investigation in Jail:
A Facilitator Guide

About this Product

“TB Contact Investigation in Jail: A Facilitator Guide” is a facilitator-led training product designed for use by correctional liaisons who are responsible for facilitating the training of jail and health department staff who conduct TB contact investigation in jail.

The content presents information about the risk of TB transmission in a jail setting, how TB can affect jail inmates and employees, and how to perform a TB contact investigation in jail.

The training is comprised of sessions that can be conducted as individual stand alone sessions or as a multi-session series. Materials include PowerPoint presentation slides, speaker notes, exercises, case studies, questions/answers key, and a master copy of all participant materials for duplication purposes.

Target audience for this training

The target audience is a combination of both jail and public health department staff who work in collaboration to conduct TB contact investigations in jail.

These can include jail staff such as correctional officers, classifications staff, senior custodial personnel, medical personnel as well as staff from the department of health, and also designated correctional liaisons partnering with corrections medical and administrative staff.

Who can facilitate

Correctional liaisons who are responsible for facilitating the training of jail and health department staff who conduct TB contact investigation in jail:

  • Public health department personnel
  • Correctional medical personnel
  • Private correctional health vendors
  • Staff in federal and state agencies
  • Staff in professional organizations, and healthcare professionals

Pre-requisite

This course is non-clinical and assumes that participants already have a basic understanding of TB pathogenesis, transmission and ongoing, regular TB infection control practices such as TB screening, surveillance, isolation, TB treatment, and latent TB infection (LTBI) treatment.

Date of Original Release

March 2008.